Overall, our data suggest that dysregulation of calcium homeostasis via expression of potentially inactivating CASR variants at rs1801725 (e.g., A986S) may be an important driver for the progression of primary neoplasms at several pathological sites, including breast, prostate, and skin, as well as metastasis to lung and bone tissues. The gene discussed is CASR; the disease is neoplasm.